Lower respiratory tract infections associated with influenza A and B viruses in an area with a high prevalence of pediatric human immunodeficiency type 1 infection

Background. Despite the high burden of pediatric HIV-1 infection in developing countries, there are few data on the clinical course of influenza virus-associated lower respiratory tract infection (LRTI) in these children. Objective. To define and compare the clinical course of HIV-1-infected and -uninfected African children hospitalized with influenza virus associated severe LRTI. Methods. Children with severe LRTI were prospectively recruited between March, 1997, and March, 1999, as part of a broader study evaluating the etiology and outcome of this condition in hospitalized HIV-1-infected and -uninfected children. The results of children in whom influenza A or B virus was identified by immunofluorescent antibody staining after shell vial culture are reported. Viruses isolated were typed by hemagglutination inhibition assays. Results. Twenty-five (21.6%) of the 116 children hospitalized with severe LRTI in whom influenza A or B virus was identified were HIV-1-infected. HIV-1-infected children were older than uninfected children (mean age ± sd 17.4 ± 10.8 months vs. 10.2 ± 8.9 months;P = 0.002). HIV-1-infected children were more likely to have an underlying medical illness (in addition to HIV-1 infection) predisposing them to more severe LRTI (32.0%vs. 13.2%;P = 0.03). HIV-infected children were also more likely to have indirect evidence of bacterial coinfection, including chest radiographic evidence of confluent alveolar consolidation (78.9%vs. 35.1%, P = 0.006), and were less likely be wheezing (8.0%vs. 31.9%, P = 0.01). However, there was no difference in the clinical outcome of HIV-1-infected and -uninfected children. The duration of hospitalization [median (range) 5 (2 to 33) days vs. 4 (0 to 21) days, P = 0.08] and the mortality rates (8.0%vs. 2.2%, P = 0.20) were similar between HIV-1-infected and -uninfected children. Conclusion. HIV-1-infected children hospitalized with severe LRTI associated with influenza virus have an outcome similar to that of HIV-1-uninfected children even in the absence of antiretroviral or anti-influenza virus treatment.

[1]  S. Madhi,et al.  Differing manifestations of respiratory syncytial virus-associated severe lower respiratory tract infections in human immunodeficiency virus type 1-infected and uninfected children. , 2001, The Pediatric infectious disease journal.

[2]  S. Madhi,et al.  Impact of human immunodeficiency virus type 1 on the disease spectrum of Streptococcus pneumoniae in South African children , 2000, The Pediatric Infectious Disease Journal.

[3]  K. K. Lai,et al.  Influenza in human immunodeficiency virus-infected patients during the 1997-1998 influenza season. , 2000, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[4]  S. Madhi,et al.  Increased burden of respiratory viral associated severe lower respiratory tract infections in children infected with human immunodeficiency virus type-1. , 2000, The Journal of pediatrics.

[5]  S. Kashiwagi,et al.  Influenza in three patients with human immunodeficiency virus infection. , 2000, Internal medicine.

[6]  N. Blackburn,et al.  Impact of the introduction of A/Sydney/5/97 H3N2 influenza virus into South Africa , 1999, Journal of medical virology.

[7]  R. Couch Editorial Response: Influenza, Influenza Virus Vaccine, and Human Immunodeficiency Virus Infection , 1999 .

[8]  R. Couch Influenza, influenza virus vaccine, and human immunodeficiency virus infection. , 1999, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[9]  J. King Community Respiratory Viruses in Individuals with Human Immunodeficiency Virus Infection , 1997, The American Journal of Medicine.

[10]  F. Hayden Prevention and treatment of influenza in immunocompromised patients. , 1997, The American journal of medicine.

[11]  A. Charlett,et al.  Response to influenza virus vaccination in vertical HIV infection , 1997, Archives of disease in childhood.

[12]  K. N. Pennington,et al.  Effect of influenza immunization on immunologic and virologic characteristics of pediatric patients infected with human immunodeficiency virus. , 1997, The Pediatric infectious disease journal.

[13]  H. Oshitani,et al.  Measles case fatality by sex, vaccination status, and HIV-1 antibody in Zambian children , 1996, The Lancet.

[14]  O. Ramilo,et al.  T cell activation and human immunodeficiency virus replication after influenza immunization of infected children. , 1996, The Pediatric infectious disease journal.

[15]  M. Kline,et al.  Prolonged influenza A infection responsive to rimantadine therapy in a human immunodeficiency virus-infected child. , 1995, The Pediatric infectious disease journal.

[16]  J. Clemens,et al.  Respiratory syncytial virus illnesses in human immunodeficiency virus- and noninfected children. , 1993, The Pediatric infectious disease journal.

[17]  P. Wright,et al.  Complex etiology of pneumonia in infants perinatally infected with human immunodeficiency virus 1. , 1991, The Pediatric Infectious Disease Journal.

[18]  R. Welliver,et al.  Respiratory syncytial virus infection in human immunodeficiency virus-infected children. , 1990, The Journal of pediatrics.

[19]  J. Mills,et al.  Influenza in patients with human immunodeficiency virus infection. , 1990, Chest.

[20]  J. Thurn,et al.  Influenza A pneumonitis in a patient infected with the human immunodeficiency virus (HIV). , 1989, Chest.

[21]  Increase in Pneumonia Mortality Among Young Adults and the HIV Epidemic , 1989, MMWR. Morbidity and mortality weekly report.

[22]  T. Waldmann,et al.  Qualitative analysis of immune function in patients with the acquired immunodeficiency syndrome. Evidence for a selective defect in soluble antigen recognition. , 1985, The New England journal of medicine.